MedPath
HSA Approval

VANCOSALA POWDER FOR SOLUTION FOR INJECTION OR INFUSION 500mg PER VIAL

SIN15417P

VANCOSALA POWDER FOR SOLUTION FOR INJECTION OR INFUSION 500mg PER VIAL

VANCOSALA POWDER FOR SOLUTION FOR INJECTION OR INFUSION 500mg PER VIAL

February 7, 2018

PAN-MALAYAN PHARMACEUTICALS PTE LTD

PAN-MALAYAN PHARMACEUTICALS PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPAN-MALAYAN PHARMACEUTICALS PTE LTD
Licence HolderPAN-MALAYAN PHARMACEUTICALS PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

INTRAVENOUS

Medical Information

J01XA01

vancomycin

Manufacturer Information

PAN-MALAYAN PHARMACEUTICALS PTE LTD

Laboratorio Reig Jofre, SA

Active Ingredients

Vancomycin Hydrochloride 512.56mg eqv to Vancomycin

500mg

Vancomycin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

VANCOSALA POWDER FOR SOLUTION FOR INJECTION OR INFUSION 500mg PER VIAL - HSA Approval | MedPath